Dear Friends and Colleagues,

It is a great pleasure to invite Researchers, Clinicians and Technology providers from all over the world to the 8th Advances in Circulating Tumor Cells meeting (ACTC2027) on “Liquid Biopsy: current status, challenges and future prospects” that will be held on October 6th – 9th 2027, in the wonderful island of Mykonos, located in the heart of the Cyclades Greek islands, Greece.

Liquid biopsy has already revealed its tremendous potential to significantly change the therapeutic strategy and management of cancer patients and even transform the early detection of cancer. The ACTC 2027 meeting (www.actc2027.org) will focus on the current status, latest advancements on CTC-related and ctDNA state of the art technologies and research, clinical applications in many types of cancer, challenges and future prospects of liquid biopsy.

We aim to bring together again a critical mass of Key Opinion Leaders in the field, world-top liquid biopsy clinicians and researchers, postgraduate and PhD students, and technology providers. We will all have once more four days to interact, establish fruitful collaborations and present state of the art data and technology innovations in the field in a wonderful, highly safe, relaxing and stimulating environment. During intense keynote, oral and poster presentation sessions, mostly unpublished cutting-edge research on the latest achievements, technical advancements and clinical trials results on CTCs, ctDNA and EVs analysis, will be discussed. Three travel grants and three poster awards will be granted to the best submitted abstracts that will be evaluated by the International Scientific Committee members. Most importantly, the 8th ACTC meeting aims to give all participants the chance to establish strong collaborations and networks in a unique, exciting and stimulating environment.

I am looking forward to welcome you in Mykonos, on October 6th – 9th 2027!!

Warm regards,

Evi S. Lianidou, PhD
University of Athens, Greece
Chair of ACTC 2027